A detailed history of Goodman Advisory Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Goodman Advisory Group, LLC holds 13,914 shares of ABBV stock, worth $2.37 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
13,914
Previous 347 3909.8%
Holding current value
$2.37 Million
Previous $63,000 3687.3%
% of portfolio
0.71%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$154.79 - $180.76 $2.1 Million - $2.45 Million
13,567 Added 3909.8%
13,914 $2.39 Million
Q3 2023

Oct 11, 2023

SELL
$133.59 - $154.65 $17,901 - $20,723
-134 Reduced 27.86%
347 $51,000
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $19,377 - $22,316
134 Added 38.62%
481 $76,000
Q2 2022

Aug 03, 2022

BUY
$137.62 - $174.96 $47,754 - $60,711
347 New
347 $53,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Goodman Advisory Group, LLC Portfolio

Follow Goodman Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goodman Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Goodman Advisory Group, LLC with notifications on news.